- The U.S. Defense Health Agency (DHA) has selected Parsons Corp PSN to provide health-related research and development and additional activities of interest for the Department of Defense and the Military Healthcare System.
- Omnibus IV is a five-year multiple-award IDIQ contract with one five-year option period and a $10 billion ceiling value.
- The Omnibus IV Military Medical Research and Development contract is a continuation of successful past government investments focused on discovering and integrating medical innovations and material solutions.
- Price Action: PSN shares are trading lower by 3.65% at $36.48 on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
